chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the second of 2 pneumonia shots in left arm and flu shot in right arm at same time.  A few hours later my left arm started aching. I could not sleep that night and the left arm felt hot and throbbed. The right arm was just a little sore. The next day I could not touch the skin on my arm and red blotches appeared, not at the injection site, but more on the inner shoulder area. For two days I felt weak and very feverish. After that abated, my left shoulder became excruciatingly painful if I moved it in a certain way. Before the shot, I had no issues with my shoulder.
Weren´t pleasant; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of discomfort in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included shingles (patient's mother had shingles).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced discomfort (Verbatim: Weren´t pleasant). The outcome of the discomfort was not reported.   It was unknown if the reporter considered the discomfort to be related to Shingles vaccine.     It was unknown if the company considered the discomfort to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 11-MAR-2023 This case was reported the patient via interactive digital media. The patient reported that he/she did not want to experience the pain that the patient mother gone through during shingles. Such extreme pain. The patient had the Shingles shots of vaccine. The patient not felt pleasant after the vaccination. The follow-up could not be possible as no contact details were available.
2 weeks post vax, the pt experienced urticaria. Treated with Zyrtex.
Red right eye; Blurry vision from right eye; This case was reported by a consumer via call center representative and described the occurrence of eye red in a 63-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2018-2019 season) for prophylaxis.   In October 2018, the patient received the 1st dose of Fluarix Quadrivalent 2018-2019 season (intramuscular). On an unknown date, 2 months after receiving Fluarix Quadrivalent 2018-2019 season, the patient experienced eye red and blurred vision. On an unknown date, the outcome of the eye red and blurred vision were recovered/resolved.   The reporter considered the eye red and blurred vision to be related to Fluarix Quadrivalent 2018-2019 season.  Additional details were provided as follows: The age at vaccination was not reported. Post vaccination the patient had eye problems with redness and blurriness of her right eye. These eye symptoms started two months after vaccination and did not resolved until April 2019. The reporter consented to follow up. This case was linked to another case US2020000878 reported for the same patient (2nd dose).
No additional AE details available.; Nurse calling to report expired MMR II was administered to a patient.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concomitant therapies included sterile diluent. The patient's concurrent conditions, medical history, allergies and drug reactions were not reported.   On 27-FEB-2022, the patient was vaccinated with an expired recombinant human albumin (rHA) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot #T007235, expiration date: 27-FEB-2022, (strength, dose, dose number, formulation, route and site of administration were not provided) for prophylaxis (expired product administered). Measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and sterile diluent had been stored according to prescribing information through the date of administration. No additional adverse events was provided (no adverse event).
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature Excursion) and EXPIRED PRODUCT ADMINISTERED (one dose was administered after the second excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature Excursion). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (one dose was administered after the second excursion). In January 2022, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature Excursion) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (one dose was administered after the second excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided by the reporter. It was reported that 80 doses Moderna Covid-19 vaccines were exposed to 2 different temperature excursions. First excursion was occurred on 14-Jan-2022 for 30 minutes with maximum temperature (-) 7.8 degrees Celsius and minimum temperature (-) 21.9 degrees Celsius. Second excursion was occurred on 21-Jan-2022 for 15 minutes with maximum temperature (-) 13.2 degrees Celsius and minimum temperature (-) 22.1 degrees Celsius. They had a total of 10 vials on hand. Out of those 10, 2 were moved from the freezer to the refrigerator on 13-Jan-2022 and one was moved on 31-Jan-2022 (total of 3 vials moved to the refrigerator). 3 vials were in the refrigerator and 7 vials were in the freezer. Everything was normal per the HCP and no vaccine state change. 80 total doses from which one dose was already administered to a patient after the second excursion. No previous excursions prior to 14-Jan-2022 and one dose administered after being punctured but the HCP did not know how many doses are still unopened and sealed. No treatment medication was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 09-Feb-2022: Follow-up information received included significant information wherein case became valid as information received about one patient
Quarter size reddened area at site of immunization with in 3 minutes.  No other signs and symptoms difficulty.
Patient received both the flu shot and PNEUMOVAX vaccine in the same arm. He reported redness and swelling of the arm that seemed to worsen. The pain started in the area of vaccine and radiated down the arm to under the elbow. He was seen at MD and prescribed cephalexin. No other symptoms.
My immediate indication that something was up was when I started feeling congestion and  my breathing implication and then I took some Benadryl at home and Prednisone (had taken some before the shot as a precaution). It did not get to a point of an anaphylactic shock just a mild reaction. I consulted my PCP afterwards regarding the second dose and he said since it was not severe and I was able to take care of it myself, I could get the second one.
Hypertension, Fast heart rate occurred 2 times after the first shot. First time heart rate went to 145. Second time heart rate went up to 130. Third time, heart rate went up to 165 the night after taking the second dose. This was at rest laying down not doing anything at all. Dizziness, lightheaded, pain in the back and side of left calf muscle. Temporary slurred speech, temporary facial numbness, felt like my face didn?t want to move or when I needed to speak and or eat and dehydration.
On 05.17.21 patient  received his first dose of the Pfizer Covid-19 vaccine (lot # EW0182 exp. 08/2022). Client's mother signaled to EMT that they needed assistance. EMT and RN responded. Client was a 16-year-old male found sitting upright and leaning forward while alert and tracking. Client had a chief complaint of ringing ears and uneasiness. Client stated that he began to notice his ears ringing a few minutes after observation began. Client's mother was unable to console the client prompting her to calmly wave for assistance. This was the client's first dose of the Pfizer vaccine. He and his mother both deny any medical history, allergies, or regular medication use. Assessment revealed no hives, rashes, discoloration, swelling, shortness of breath or other signs of anaphylaxis. Client complained of unspecified uneasiness while leaning forward but exhibited no accessory muscle use. Client denied any pain throughout his body. Airway, breathing and circulation were intact. Client stated that he was "nervous" before receiving his vaccine today due to stories he had heard from his peers. Client then stated that he felt like he "couldn't move [his] hands" despite there being no obvious range of motion compromise. Vitals at 1332 were pulse 76, O2 100%, lung sounds clear bilaterally, alert and oriented to person, place, date and event, respirations 20. Client and mother both consented to an additional 30 minutes. Client was assisted from his observation chair to a bed by EMT and mother and stayed there for the remainder of his observation. After approximately five minutes of lying down, the client stated that he felt "much better." Remaining vitals: 1337 - 118/78, O2 99%, Resp. 16, HR 76, 1349 - 110/76, HR 72, O2 99%, Resp. 16. 1402 118/78, O2 100%, HR 72, Resp. 16. Client's mother was provided with all relevant vaccine information and instructed to seek medical attention if further concerns arise in the evening. Client denied EMS transport. Client completed his observation at 1402 and departed with his mother at 1402 in positive disposition with steady gait asking his mother if he could go out and "skate".
Tested positive for Covid-19 at Urgent Care on 05 19 21.  Symptoms started on 05 15 21.  Very ill with headache, sinus pressure, congestion, cough, fever, sore throat, loss of taste and smell, nausea, fatigue.  No hospitalization.  Loss of taste and smell and the fatigue continue 7 weeks later.   Caught it after coming into extended contact with sick, unmasked, and unvaccinated co-worker.
I woke up on November 18th, 2022 and my entire lower body from my waist down was numb. It was hard to walk and even stand up. I didn't get any better and went to an urgent care the next day Saturday the 19th. The doctor strongly suggested I go to an emergency room and get a MRI. I was dropped off at Hospital and after a couple MRIs and CAT scans. I was transferred to Hospital where I stayed for 7 days. Initially the theory for several days was I had MS. After I had a spinal tap, the doctors at hospital has a few other ideas and didn't think it was MS anymore. After leaving the hospital I had a PET scan and additional MRIs. I have another spinal tap that will occur in February. At the moment nothing is 100%, but hopefully the information from the next spinal tap will give the neurologist more insight.
101.6 degree Fever, chills, body aches, headache, dizziness,
BREAKTHROUGH COVID 19 CASE AFTER COMPLETED VACCINE SERIES  2 DOSES OF PFIZER VACCINE GIVEN-  1/5/2021 EL0140 AND 1/26/2021 EL3302 ASYMPTOMATIC POSITIVE PCR TEST ON 4/12/2021;   REMAINS ASYMPTOMATIC
Swelling, redness for one week then decreased ROM and pulling sensation in arm for two weeks.
pt recvd vax; devel rash w/ approx 100 lesions all over body;
Pt devel fever, sore throat, h/a & severe nausea & vomiting p/receiving flu vax; 4 days later, pt devel shock & was hospitalized; pt condition subsequently improved; Reporter was not aware of any allergies in pt;
Vaccine was the FLUZONE high dose vaccine for seniors. Weakness & body aches followed by sore muscles & joints. Coughing & sore throat for 3 hours. Had to sleep for 10 hours with doses of nsaids & acetominophen. Unable to stay awake during the day for 3 days, sleeping & bed rest for 12-14 hours/day. Unable to resume normal activities until 5th day, Nov. 2nd. Had to consume max doses of OTC pain medication through 5th day. I have had annual flu vaccination for many years, starting in the the 1960s. Never had more than minor discomfort resulting from standard dose vaccine.
Approximately 3-4 weeks after receiving the vaccine I developed severe diarrhea every day, all day long.  I never experienced this before and it lasted for four months straight until I started keeping a food journal. I eventually eliminated all gluten, dairy, beans, tree nuts, oats and several fruits and vegetables from my diet which has helped control the diarrhea. Even still I have flare ups despite not eating any of the "trigger" foods.
This spontaneous report was received from a registered nurse (R.N.) concerning to an 18 year old male patient with non drug reaction allergies. On 15-JUL-2013 the patient was vaccinated with GARDASIL (lot # H021608, expiration date 13-AUG-2015) (0.5 ml, intramuscular route). In 2013, after receiving GARDASIL the patient experienced fatigue and mood issues. The patient was to follow-up with office visit, if fatigue and mood issues persisted. Physician was informed by patient's mother on 14-AUG-2013, that patient experienced swelling of face and joint pain, that occurred one day after patient received GARDASIL, on 16-JUL-2013; however, swelling of face and joint pain had resolved. It was also reported that on 15-JUL-2013 the patient was diagnosed with sinusitis and conduct disorder. The patient called the physician and no treatment was given for the adverse events. The outcome of swelling of face and joint pain was reported as recovered and the outcome of fatigue, mood issues, sinusitis and conduct disorder was unknown. Additional information has been requested.
Severe arm site stiffness and soreness. Dizziness, tingling feeling all over body/ light headed disoriented/ confusion, chills nausea/vomiting several times,  severe headache , loss of taste and smell, diarrhea several times, hair loss, blacked out for a few seconds in the shower resulting in a fall. Low blood pressure the next day ( today). Fatigued, muscle aches, chills. I?ve taken Tylenol as instructed and  peptobismal. Sleept most of the day. Had to call out of work.
Patient had significant arm swelling, redness and pain the evening she got the shot. It lasted about 1 month. She then got an active shingles outbreak on 7/9/18.
606 doses were given after expiration date; Vaccine kept in refrigerator on 10/04/2021, expiration date is 10/13/2021, administered on 10/15/2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 10/04/2021, expiration date is 10/13/2021, administered on 10/15/2021) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 10/04/2021, expiration date is 10/13/2021, administered on 10/15/2021). On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 10/04/2021, expiration date is 10/13/2021, administered on 10/15/2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was placed in the refrigerator was 04-Oct-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
This spontaneous report as received from a health care worker refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with ROTATEQ. Dose, route, lot number and expiration date were not reported. The health care worker reported that ROTATEQ was improperly stored and administered to unspecified number of patients on unspecified dates. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Patient has episode of amnesia possibly cause by seizure. Patient also had headache, chills, fatigue.
Next night vomited, fever, chills, back pain, extreme fatigue, inability to eat, lack of coordination in legs, confusion ...lasted for 4 days now. Worse symptoms when temperature is high.
1 hour after administration pt experienced pain and cramping throughout her right arm. 2 days later, pt reports having minor facial swelling, particularly around the eyes. Pt also reports taking Advil sometime after the dose was administered but prior to experiencing the facial swelling. Pt also reports that these adverse events did not occur with her 1st dose.
Moderna COVID-19 Vaccine EUA. On 10/27/21, I felt a blueberry size, hard lump under my skin below my left clavicle. On 11/04/21, I developed a localized rash at the site of my Covid-19 vaccine injection. I then called the Nurse Line for Tricare to speak to an RN on 11/05/21. That RN told me to monitor the rash, and that the lump was most likely lymphadenopathy which should resolve itself within around a month. The rash on my left arm went away on 11/08/21. I developed a new onset shortness of breath and a tight feeling around my lungs on 11/09/21. The lymphadenopathy and SOB has not yet been resolved.
Presented to ED due to suicidal ideation. Behavioral health admission and treatment. Hospital admission was within 6 weeks of receiving the COVID vaccine.
Pt recvd 3 doses of Engerix-B & titers were checked 6 months p/last dose & titer was neg;
MMR II should have been given instead of proquad. Pt also received varivax this day.
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021 at 9:20 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Feb-2021 at 9:20 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 71.91 years Concomitant products were not provided. On 17-Feb-2021, Excursion time was 9 AM, temp was 22 , condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 11-Feb-2021, vial was moved to clinic on 17-Feb-2021. 5 vial was moved to clinic. Vaccine BUD date was 13-Mar-2021. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were took by using a Fisherbrand traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. Treatment medications were not reported.
a lump on the right side of her neck around the clavicle area that was half the size of a tennis ball, her doctor said said that a lymph node possibly became swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (a lump on the right side of her neck around the clavicle area that was half the size of a tennis ball, her doctor said said that a lymph node possibly became swollen) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F21A, 012A21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (a lump on the right side of her neck around the clavicle area that was half the size of a tennis ball, her doctor said said that a lymph node possibly became swollen). At the time of the report, LYMPHADENOPATHY (a lump on the right side of her neck around the clavicle area that was half the size of a tennis ball, her doctor said said that a lymph node possibly became swollen) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that, on 27-Nov-2021, a lymph node possibly became swollen. It had been subsided, but still feel it and see it. It was about a 1/4 the size of a tennis ball. No concomitant and treatment medications were reported.